tiprankstipranks
AlzChem Group AG (CH:ACT)
:ACT
Switzerland Market

AlzChem Group AG (ACT) Ratios

0 Followers

AlzChem Group AG Ratios

CH:ACT's free cash flow for Q2 2026 was €0.32. For the 2026 fiscal year, CH:ACT's free cash flow was decreased by € and operating cash flow was €0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.70 2.49 2.48 2.62 1.62
Quick Ratio
1.74 1.52 1.52 1.32 0.70
Cash Ratio
0.58 0.60 0.58 0.14 0.07
Solvency Ratio
0.24 0.25 0.29 0.23 0.20
Operating Cash Flow Ratio
1.02 1.15 1.00 0.88 -0.03
Short-Term Operating Cash Flow Coverage
14.31 21.52 13.86 8.23 -0.06
Net Current Asset Value
€ -93.90M€ -62.79M€ -14.56M€ -44.54M€ -62.28M
Leverage Ratios
Debt-to-Assets Ratio
0.13 0.07 0.11 0.15 0.24
Debt-to-Equity Ratio
0.33 0.17 0.26 0.39 0.70
Debt-to-Capital Ratio
0.25 0.15 0.20 0.28 0.41
Long-Term Debt-to-Capital Ratio
0.23 0.12 0.17 0.23 0.16
Financial Leverage Ratio
2.50 2.41 2.35 2.63 2.94
Debt Service Coverage Ratio
8.88 10.51 8.38 5.97 0.82
Interest Coverage Ratio
42.04 47.72 31.49 19.99 12.89
Debt to Market Cap
0.05 0.03 0.08 0.22 0.55
Interest Debt Per Share
9.12 4.55 5.42 6.40 10.15
Net Debt to EBITDA
0.21 -0.25 -0.08 0.62 1.34
Profitability Margins
Gross Profit Margin
14.22%31.59%29.43%56.24%52.14%
EBIT Margin
15.33%14.73%14.01%9.40%8.17%
EBITDA Margin
20.14%19.47%18.76%15.12%12.55%
Operating Profit Margin
15.21%14.73%13.05%9.66%7.21%
Pretax Profit Margin
16.18%15.64%13.59%8.91%7.61%
Net Profit Margin
11.72%11.29%9.76%6.40%5.54%
Continuous Operations Profit Margin
11.75%11.32%9.79%6.44%5.57%
Net Income Per EBT
72.39%72.16%71.77%71.84%72.80%
EBT Per EBIT
106.40%106.22%104.16%92.24%105.62%
Return on Assets (ROA)
10.05%10.27%11.18%8.15%7.11%
Return on Equity (ROE)
26.12%24.76%26.31%21.42%20.87%
Return on Capital Employed (ROCE)
15.71%16.60%19.11%15.27%13.44%
Return on Invested Capital (ROIC)
11.24%11.81%13.43%10.70%7.97%
Return on Tangible Assets
10.11%10.33%11.26%8.22%7.16%
Earnings Yield
4.10%4.05%9.32%12.99%17.47%
Efficiency Ratios
Receivables Turnover
5.93 5.94 6.54 6.59 8.77
Payables Turnover
10.26 7.43 10.45 7.10 6.94
Inventory Turnover
4.51 3.31 3.87 2.08 2.12
Fixed Asset Turnover
1.75 2.01 2.81 2.97 2.89
Asset Turnover
0.86 0.91 1.15 1.27 1.28
Working Capital Turnover Ratio
3.12 3.36 3.82 4.99 6.82
Cash Conversion Cycle
106.95 122.47 115.27 179.06 161.09
Days of Sales Outstanding
61.56 61.45 55.79 55.39 41.63
Days of Inventory Outstanding
80.94 110.11 94.40 175.07 172.05
Days of Payables Outstanding
35.56 49.10 34.92 51.40 52.59
Operating Cycle
142.51 171.56 150.20 230.46 213.68
Cash Flow Ratios
Operating Cash Flow Per Share
11.51 13.56 10.33 7.14 -0.42
Free Cash Flow Per Share
1.85 3.88 6.10 5.12 -3.27
CapEx Per Share
9.66 9.68 4.24 2.02 2.86
Free Cash Flow to Operating Cash Flow
0.16 0.29 0.59 0.72 7.86
Dividend Paid and CapEx Coverage Ratio
0.85 1.18 1.90 2.33 -0.11
Capital Expenditure Coverage Ratio
1.19 1.40 2.44 3.54 -0.15
Operating Cash Flow Coverage Ratio
1.29 3.10 1.99 1.16 -0.04
Operating Cash Flow to Sales Ratio
0.20 0.24 0.19 0.13 >-0.01
Free Cash Flow Yield
1.13%2.50%10.70%19.55%-19.37%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
24.36 24.68 10.73 7.70 5.72
Price-to-Sales (P/S) Ratio
2.86 2.79 1.05 0.49 0.32
Price-to-Book (P/B) Ratio
6.12 6.11 2.82 1.65 1.19
Price-to-Free Cash Flow (P/FCF) Ratio
88.40 39.94 9.35 5.12 -5.16
Price-to-Operating Cash Flow Ratio
14.18 11.43 5.52 3.67 -40.56
Price-to-Earnings Growth (PEG) Ratio
1.42 1.35 0.19 0.53 0.62
Price-to-Fair Value
6.12 6.11 2.82 1.65 1.19
Enterprise Value Multiple
14.39 14.06 5.49 3.88 3.86
Enterprise Value
1.68B 1.54B 571.21M 317.23M 262.97M
EV to EBITDA
14.39 14.06 5.49 3.88 3.86
EV to Sales
2.90 2.74 1.03 0.59 0.48
EV to Free Cash Flow
89.71 39.24 9.21 6.09 -7.90
EV to Operating Cash Flow
14.40 11.23 5.43 4.37 -62.02
Tangible Book Value Per Share
26.49 25.20 20.03 15.71 14.05
Shareholders’ Equity Per Share
26.66 25.36 20.20 15.88 14.15
Tax and Other Ratios
Effective Tax Rate
0.27 0.28 0.28 0.28 0.27
Revenue Per Share
57.14 55.62 54.47 53.13 53.28
Net Income Per Share
6.69 6.28 5.31 3.40 2.95
Tax Burden
0.72 0.72 0.72 0.72 0.73
Interest Burden
1.06 1.06 0.97 0.95 0.93
Research & Development to Revenue
0.02 0.02 0.02 0.02 0.02
SG&A to Revenue
0.20 0.12 0.06 0.02 0.02
Stock-Based Compensation to Revenue
<0.01 0.00 <0.01 <0.01 <0.01
Income Quality
1.57 2.16 1.94 2.10 -0.10
Currency in EUR